News from oncopeptides ab

Aug 20, 2013, 09:00 ET

Oncopeptides Initiates Phase II Clinical Study with Melflufen in the Treatment of Multiple Myeloma Patients

Oncopeptides AB, a company working to enhance oncology therapies, today announced that the first patient has been dosed as part of a Phase II...

May 21, 2013, 08:00 ET

Oncopeptides Secures Venture Funding for Phase II Trial of Melflufen in Multiple Myeloma Patients

Oncopeptides AB, a company working to enhance oncology therapies, today announced the conclusion of a series A financing round intended to fund...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Analysts Review